Intel has reportedly landed a deal for a $25 billion terafab, which may be a significant development for the company's foundry business. The deal is said to involve companies associated with Elon Musk and could potentially boost US chip production. The implications of the deal are still uncertain, with some outlets suggesting it could be a major catalyst for Intel's turnaround, while others are more skeptical.